Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Shares Climb 0.6% – What’s Next?

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) shot up 0.6% during trading on Monday. The company traded as high as $126.80 and last traded at $125.80. Approximately 40,426 shares were traded during mid-day trading, an increase of 12% from the average daily volume of 36,011 shares. The stock had previously closed at $125.03.

Invesco Pharmaceuticals ETF Price Performance

The company has a market capitalization of $558.55 million, a P/E ratio of 15.59 and a beta of 0.44. The stock has a 50-day moving average price of $125.83 and a 200-day moving average price of $113.90.

Institutional Trading of Invesco Pharmaceuticals ETF

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. lifted its position in shares of Invesco Pharmaceuticals ETF by 35.9% in the 2nd quarter. Envestnet Asset Management Inc. now owns 36,897 shares of the company’s stock worth $4,370,000 after purchasing an additional 9,741 shares during the period. Royal Bank of Canada boosted its stake in shares of Invesco Pharmaceuticals ETF by 479.8% in the 1st quarter. Royal Bank of Canada now owns 62,377 shares of the company’s stock valued at $6,472,000 after purchasing an additional 51,619 shares during the last quarter. Bank of America Corp DE boosted its stake in shares of Invesco Pharmaceuticals ETF by 234.0% in the 1st quarter. Bank of America Corp DE now owns 74,458 shares of the company’s stock valued at $7,726,000 after purchasing an additional 52,165 shares during the last quarter. Cetera Investment Advisers increased its position in shares of Invesco Pharmaceuticals ETF by 250.7% during the first quarter. Cetera Investment Advisers now owns 20,462 shares of the company’s stock worth $2,123,000 after buying an additional 14,628 shares during the period. Finally, Private Advisor Group LLC acquired a new stake in shares of Invesco Pharmaceuticals ETF during the first quarter worth $610,000.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.